Skip to main content

Advertisement

SpringerLink
Log in

Evidence for Aberrant Regulation of MAP Kinase Signal Transduction Pathway in Peripheral Blood Mononuclear Cells in Patients with Active Celiac Disease

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background Aberrant signaling via the p21/mitogen-activated proteins (MAP) kinase pathway has been described in lymphocytes of patients with various autoimmune diseases. There is little published data about the intracellular mediators and signals that regulate expression and activity of transcription factors and their effect on celiac disease induction and progression. Aim To investigate the possible involvement of MAP kinase pathway in peripheral blood mononuclear cells (PBMC) in celiac disease and its correlation with disease activity. Methods Expression of the total and activated forms of two MAP kinases [extracellular response kinase (ERK) and c-Jun amino terminal kinase (JNK)] were studied by Western blots in PBMC of 17 untreated and 19 treated celiac patients, and 17 controls. Seven of these untreated celiac patients were studies before and after 6 months of gluten-free diet. Results Phosphorylated ERK of active celiac disease patients was significantly lower compared with controls (P < 0.01) and was increased towards normal after 6 month of gluten-free diet (P < 0.01). Phosphorylated JNK was increased significantly in the untreated celiac group (P < 0.01) and normalized towards the control level after 6 months of gluten-free diet (P < 0.04). Conclusions Aberrant MAP-kinase pathway activity is associated with active celiac disease (CD). Further studies should examine the potential role of this aberration in pathogenesis of CD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. National Institute of Health Consensus Development Conference Statement on Celiac Disease, 2004. Gastroenterology. 2005;128(suppl):S1–S9.

    Google Scholar 

  2. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med. 2002;346:180–188. doi:10.1056/NEJMra010852.

    Article  PubMed  CAS  Google Scholar 

  3. Kagnoff MF. Coeliac disease: genetic immunological and environmental factors in disease pathogenesis. Scand J Gastroenterol. 1985;114(suppl):45–54. doi:10.3109/00365528509093767.

    Google Scholar 

  4. Kagnoff MF. Immunopathogenesis of celiac disease. Immunol Invest. 1989;18:499–508. doi:10.3109/08820138909112259.

    Article  PubMed  CAS  Google Scholar 

  5. Kagnoff MF. Understanding the molecular basis of celiac disease. Gut. 1990;31:497–499. doi:10.1136/gut.31.5.497.

    Article  PubMed  CAS  Google Scholar 

  6. Nalual AT, Nilsson S, Gudjonsdottir AH, et al. Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosome 5 and 11. Eur J Hum Genet. 2001;9:938–944. doi:10.1038/sj.ejhg.5200752.

    Google Scholar 

  7. Rincon M, Flavell RA, Davis RA. The JNK and P38 MAP kinase signaling pathway in T cell-mediated immune responses. Free Radic Biol Med. 2000;28:1328–1337. doi:10.1016/S0891-5849(00)00219-7.

    Article  PubMed  CAS  Google Scholar 

  8. Zhang YL, Dong C. MAP kinases in immune respon. Cell Mol Immunol. 2005;2:20–27.

    PubMed  CAS  Google Scholar 

  9. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol. 2002;20:55–72. doi:10.1146/annurev.immunol.20.091301.131133.

    Article  PubMed  CAS  Google Scholar 

  10. Rapoport MJ, Lazarus AH, Jaramillo A, et al. Thymic T cell anergy in autoimmune non-obese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation. J Exp Med. 1993;177:1221–1226. doi:10.1084/jem.177.4.1221.

    Article  PubMed  CAS  Google Scholar 

  11. Gross DJ, Sidi H, Weiss A, et al. Prevention of diabetes mellitus in non-obese diabetic mice by Linomide-a novel immunomodulator drug. Diabetologia. 1994;37:1195–1201. doi:10.1007/BF00399792.

    Article  PubMed  CAS  Google Scholar 

  12. Rapoport MJ, Weiss L, Mor A, et al. Prevention of autoimmune diabetes by Linomide in NOD mice is associated with upregulation of the T cell receptor mediated activation of p21ras. J Immunol. 1996;157:4721–4725.

    PubMed  CAS  Google Scholar 

  13. Salojin K, Zhang J, Cameron M, et al. Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-ζ-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice. J Exp Med. 1997;186:887–897. doi:10.1084/jem.186.6.887.

    Article  PubMed  CAS  Google Scholar 

  14. Rapoport MJ, Amit M, Aharoni D, et al. Constitutive up-regulated activity of MAP kinase is associated with down regulated early p21ras pathway in lymphocytes of SLE patients. JAI. 2002;19:63–70.

    Google Scholar 

  15. Rapoport MJ, Mor A, Amit M, et al. Decreased expression of the p21 ras stimulatory factor hSOS in PBMC from inactive SLE patients. Lupus. 1999;8:24–28. doi:10.1191/096120399678847362.

    Article  PubMed  CAS  Google Scholar 

  16. Waetzig GH, Seegert D, Rosenstiel P, et al. p38 mitogen activated protein kinase is activated and linked to TNF-α signaling in inflammatory bowel disease. J Immunol. 2002;168:5342–5351.

    PubMed  CAS  Google Scholar 

  17. van Nontfrans C, Peppelenbosch M, te Veld AA, et al. Inflammatory signal transduction in Crohn’s disease and novel therapeutic approaches. Biochem Pharmacol. 2002;64:789–795.

    Article  Google Scholar 

  18. Hommes D, Van den Blink B, Plasse T, et al. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn’s disease. Gastroenterology. 2002;122:7–14.

    Article  PubMed  CAS  Google Scholar 

  19. Van den Blink B, Ten Hovve T, Van den Brink GR. From extracellular targets, inhibitng MAP kinases in treatment of Crohn’s disease. Ann NY Acad Sci. 2002;973:349–358.

    Article  Google Scholar 

  20. Confino-Cohen R, Aharoni D, Goldberg A, et al. Evidence for aberrant regulation of the p21ras pathway in PBMCs of patients with chronic idiopathic urticaria. J Allergy Clin Immunol. 2002;109:349–356.

    Article  PubMed  CAS  Google Scholar 

  21. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature. 1993;366:643–654.

    Article  PubMed  CAS  Google Scholar 

  22. Dewar DH, Ciclitira PJ. Clinical features and diagnosis of celiac disease. Gastroenterology. 2005;128(suppl):S19–S24.

    Article  PubMed  Google Scholar 

  23. Hill ID. What are the sensitivity and specificity of serologic test for celiac disease? Do sensitivity and specifity vary in different populations? Gastroenterology. 2005;128(suppl):S25–S32.

    Article  PubMed  Google Scholar 

  24. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: a conserved switch to diverse cell function. Nature. 1990;348:125–131.

    Article  PubMed  CAS  Google Scholar 

  25. Izquiero PM, Reif K, Cantrell D. The regulation and function of p21ras during T-cell activation and growth. Immunol Today. 1995;16:672–676.

    Google Scholar 

  26. Finkel TH, Marrack P, Kappler JW, et al. Alpha beta T cell receptor and CD3 transduce different signals in immature T cells. Implications for selection and tolerance. J Immunol. 1989;142:3006–3012.

    PubMed  CAS  Google Scholar 

  27. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nature Med. 2001;7:899–905.

    Article  PubMed  CAS  Google Scholar 

  28. Jelikova LP, Rozkova D, Pecharova B, et al. Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. J Immunol. 2005;175:7038–7045.

    Google Scholar 

  29. Di Sabatino A, D’Alo S, Millimaggi D, et al. Apoptosis and peripheral blood lymphocyte depletion in celiac disease. Immunology. 2001;103:435–440.

    Article  PubMed  CAS  Google Scholar 

  30. Maiuri L, Clacci C, Ricciardelli I, et al. Association between innate respons to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003;362:30–37.

    Article  PubMed  CAS  Google Scholar 

  31. Matsumoto N, Imamura R, Suda T. Caspase-8-and JNK-dependent AP-1 activation is required for FAS ligand-induced IL-8 production. FEBS J. 2007;274:2376–2384.

    Article  PubMed  CAS  Google Scholar 

  32. Pahl A, Zhang M, Kuss H, et al. Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells. J Iummunol. 2003;170:2427–2434.

    Google Scholar 

  33. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic Autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9:243–269.

    Article  PubMed  CAS  Google Scholar 

  34. Steinberg AD, Klinman DM, Kastner DL, et al. Genetic and molecular genetic studies of murine and human lupus. J Rheumatol. 1987;14(suppl):166–176.

    Google Scholar 

  35. Rapoport MJ, Mor A, Vardi P, et al. Defective activation of p21ras in peripheral blood mononuclear cells from patients with insulin dependent diabetes mellitus. Autoimmunity. 1999;29:147–154.

    Article  PubMed  CAS  Google Scholar 

  36. Sharabani A, Haviv A, Zinger H, Dayan M, Mozes E. Amelioration of murine lupus by a peptide based on the complemtarity determining region-1 of an autoantibody as compared to dexamethasone. Different effects on cytokines and apoptosis. Immunology. 2007;121:248–257.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Gastroenterology and Liver Diseases, Assaf Harofeh Medical Center Affiliated to Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    E. Broide, E. Scapa, M. Shapiro, N. A. Kimchi & G. Ben-Yehudah

  2. Endocrinology and Diabetes Unit, Assaf Harofeh Medical Center Affiliated to Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    O. Bloch & M. J. Rapoport

Authors
  1. E. Broide
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Scapa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Bloch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Shapiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. A. Kimchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Ben-Yehudah
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. J. Rapoport
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Broide.

Additional information

E. Broide MD and E. Scapa MD have contributed equally to this paper and therefore should be considered first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Broide, E., Scapa, E., Bloch, O. et al. Evidence for Aberrant Regulation of MAP Kinase Signal Transduction Pathway in Peripheral Blood Mononuclear Cells in Patients with Active Celiac Disease. Dig Dis Sci 54, 1270–1275 (2009). https://doi.org/10.1007/s10620-008-0480-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0480-y

Keywords

Search

Navigation